Fig. 5: Anti-bacilli treatment or supplement of A. muciniphila ameliorate DSS-induced colitis in RAI16−/− mice. | Cell Death & Disease

Fig. 5: Anti-bacilli treatment or supplement of A. muciniphila ameliorate DSS-induced colitis in RAI16−/− mice.

From: Retinoid acid induced 16 deficiency aggravates colitis and colitis-associated tumorigenesis in mice

Fig. 5

a Gut microbiota levels of WT and RAI16−/− mice. b Quantitative analysis of total gut bacterial burden in the feces of mice using qPCR. c Quantitative analysis of bacilli and A. muciniphila in the feces of mice using qPCR. WT and RAI16−/− mice were treated ciprofloxacin oral or supplementated with A. muciniphila for 5 days and then given 3% DSS for 6 days and water for an additional 3 day. Severity of colitis were assessed by measuring body weights loss d and colon lengths e. Colitis severity was assessed using disease activity index f and histological scores g. Data represent one of three independent experiments. Data shown are mean ± SD. *p < 0.05; **p < 0.01; #p < 0.05; ##p < 0.01.

Back to article page